The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis

Pinyi Liu,Yanbing Wang,Ge Yang,Qihe Zhang,Lingbin Meng,Ying Xin,Xin Jiang

DOI: https://doi.org/10.1016/j.phrs.2021.105420

IF: 10.334

2021-03-01

Pharmacological Research

Abstract:<p>Short-chain fatty acids (SCFAs), mainly including acetate, propionate, and butyrate, are metabolites produced during the bacterial fermentation of dietary fiber in the intestinal tract. They are believed to be essential factors affecting host health. Most <em>in vitro</em> and <em>ex vivo</em> studies have shown that SCFAs affect the regulation of inflammation, carcinogenesis, intestinal barrier function, and oxidative stress, but convincing evidence in humans is still lacking. Two major SCFA signaling mechanisms have been identified: promotion of histone acetylation and activation of G-protein-coupled receptors. In this review, we introduce the production and metabolic characteristics of SCFAs, summarize the potential effects of SCFAs on the four aspects mentioned above and the possible mechanisms. SCFAs have been reported to exert a wide spectrum of positive effects and have a high potential for therapeutic use in human-related diseases.</p>

pharmacology & pharmacy

What problem does this paper attempt to address?

The paper primarily explores the roles of short-chain fatty acids (SCFAs) in gut barrier function, inflammation, oxidative stress, and the development of colorectal cancer, and attempts to reveal their potential mechanisms. SCFAs mainly include acetate, propionate, and butyrate, which are metabolic products produced by bacterial fermentation of dietary fiber in the gut. The study points out that SCFAs affect host health through various pathways, such as regulating inflammatory responses, inhibiting cancer development, maintaining gut barrier integrity, and combating oxidative stress.

Although in vitro and ex vivo studies indicate that SCFAs have significant effects on the aforementioned aspects, conclusive evidence in humans is still lacking. The paper also discusses two main signaling mechanisms of SCFAs: promoting histone acetylation and activating G-protein-coupled receptors. Additionally, the authors emphasize the potential of SCFAs in the treatment of related diseases and propose that oxidative stress may be a key driving factor connecting multiple elements in the pathogenesis of colorectal diseases.

In summary, the paper aims to provide a comprehensive introduction to the production and metabolic characteristics of SCFAs, summarize their effects on gut barrier function, inflammation, oxidative stress, and the development of colorectal cancer, and their possible mechanisms of action, in order to provide a theoretical basis for future research.